Nathalie Strub‐Wourgaft
Biographic Data
| ID | 8990220 |
|---|---|
| NAME | Nathalie Strub‐Wourgaft |
| GIVEN NAMES | Nathalie |
| FAMILY NAME | Strub‐Wourgaft |
| SIGNATURE | WOURGAFT N S |
| AFFILIATIONS | Drugs for Neglected Diseases Initiative |
| ORCID | 0000-0001-9915-6934 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Definitions matter
Therapeutic efficacy in COVID-19 is dependent upon disease severity (treatment effect heterogeneity). Unfortunately, definitions of severity vary widely. This compromises the meta-analysis of randomised controlled trials (RCTs) and the therapeutic guidelines derived from them. The World Health Organisation ‘living’ guidelines for the treatment of COVID-19 are based on a network meta-analysis (NMA) of published RCTs. We reviewed the 81 studies inc…
Improving the Quality of Host Country Ethical Oversight of International Research
Developing countries face numerous barriers to conducting effective and efficient ethics reviews of international collaborative research. In addition to potentially overlooking important scientific and ethical considerations, inadequate or insufficiently trained ethics committees may insist on unwarranted changes to protocols that can impair a study's scientific or ethical validity. Moreover, poorly functioning review systems can impose substanti…
No prominent works on this page.
Improving the Quality of Host Country Ethical Oversight of International Research
Developing countries face numerous barriers to conducting effective and efficient ethics reviews of international collaborative research. In addition to potentially overlooking important scientific and ethical considerations, inadequate or insufficiently trained ethics committees may insist on unwarranted changes to protocols that can impair a study's scientific or ethical validity. Moreover, poorly functioning review systems can impose substanti…
Definitions matter
Therapeutic efficacy in COVID-19 is dependent upon disease severity (treatment effect heterogeneity). Unfortunately, definitions of severity vary widely. This compromises the meta-analysis of randomised controlled trials (RCTs) and the therapeutic guidelines derived from them. The World Health Organisation ‘living’ guidelines for the treatment of COVID-19 are based on a network meta-analysis (NMA) of published RCTs. We reviewed the 81 studies inc…
Medicine (2 works) · Biomedical Ethics and Regulation (1 work) · Business (1 work) · COVID-19 Clinical Research Studies (1 work) · Critical illness (1 work) · Critically ill (1 work) · Disease (1 work) · Engineering ethics (1 work) · Ethics in Clinical Research (1 work) · Global Health and Surgery (1 work)